Form 4: Hims & Hers Health, Inc. Executive Granted Restricted Stock Units

Chief Medical Officer Patrick Harrison Carroll received 9,935 Restricted Stock Units (RSUs) convertible to Class A Common Stock, vesting by June 15, 2025, or the 2025 annual meeting, as per a recent SEC Form 4 filing.

Summary

• Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., was granted 9,935 Restricted Stock Units (RSUs) on August 7, 2024.
• Each RSU represents a contingent right to receive one share of Class A Common Stock.
• The RSUs will vest on the earlier of the date of the 2025 annual meeting of stockholders or June 15, 2025, subject to continuous service.
• Following the transaction, Carroll directly owns 9,935 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the executive's continued service. It's a routine event, but positive for alignment of interests.

Positives

• The grant of RSUs aligns the executive's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The vesting of the RSUs is contingent upon continuous service, suggesting an expectation of the executive's continued involvement with the company.

Industry Context

Grants of restricted stock units are a common form of executive compensation in the health and wellness industry, aligning management incentives with shareholder value.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns executive compensation with company performance.

Key Dates